Literature DB >> 20207770

Comparison of cystatin C and creatinine as predictors of cardiovascular events in a community-based elderly population.

John Beilby1, Mark L Divitini, Matthew W Knuiman, Enrico Rossi, Joseph Hung.   

Abstract

BACKGROUND: Reduced renal function is an established risk factor for cardiovascular events. We compared 3 measures of renal function--serum cystatin C, serum creatinine, and calculated creatinine clearance--as predictors of subsequent cardiovascular events in a community-based population of elderly individuals.
METHODS: Comprehensive cardiovascular risk factor data were available for 1410 surviving participants of previous Busselton health surveys who were >or=60 years old. Hazard ratios for risk of incident coronary heart disease and cardiovascular disease over 10 years of follow-up were derived for each baseline measure of renal function by use of Cox regression.
RESULTS: All measures of renal function were significantly related to risks of morbidity and mortality from coronary heart disease and cardiovascular disease. There were 453 incident cardiovascular disease events; and the age- and sex-adjusted hazard ratios (95% CIs) were 1.34 (1.23-1.46), 1.32 (1.20-1.45), and 1.22 (1.06-1.41) per 1-SD deterioration in cystatin C, creatinine, and creatinine clearance, respectively. All 3 measures gave approximately the same age-adjusted relative risk estimates. After further adjustment for established cardiovascular risk factors, the relative risk estimates were all reduced but remained statistically significant (P < 0.05). Cystatin C was not a significant predictor for cardiovascular disease after adjustment for creatinine clearance.
CONCLUSIONS: In relation to predicting risk for coronary heart disease or cardiovascular disease over a 10-year follow-up in a community-based population of elderly subjects, there was no evidence that cystatin C was a better risk predictor than creatinine or creatinine clearance.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20207770     DOI: 10.1373/clinchem.2009.135962

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  6 in total

1.  A cohort study examination of established and emerging risk factors for atrial fibrillation: the Busselton Health Study.

Authors:  Matthew Knuiman; Tom Briffa; Mark Divitini; Derek Chew; John Eikelboom; Brendan McQuillan; Joseph Hung
Journal:  Eur J Epidemiol       Date:  2014-01-04       Impact factor: 8.082

2.  Serum cystatin C as a biomarker for predicting coronary artery disease in diabetes.

Authors:  Jee-Young Oh
Journal:  Korean Diabetes J       Date:  2010-04-30

Review 3.  Is the presence of microalbuminuria a relevant marker of kidney disease?

Authors:  Richard J Glassock
Journal:  Curr Hypertens Rep       Date:  2010-10       Impact factor: 5.369

4.  Cystatin C Predicts Incident Cardiovascular Disease in Twins.

Authors:  Johannes Arpegård; Patrik K E Magnusson; Xu Chen; Peter Ridefelt; Nancy L Pedersen; Ulf De Faire; Per Svensson
Journal:  J Am Heart Assoc       Date:  2016-06-27       Impact factor: 5.501

5.  Targeted metabolomic analysis of plasma metabolites in patients with coronary heart disease in southern China.

Authors:  Zhixiong Zhong; Jing Liu; Qifeng Zhang; Wei Zhong; Bin Li; Cunren Li; Zhidong Liu; Min Yang; Pingsen Zhao
Journal:  Medicine (Baltimore)       Date:  2019-02       Impact factor: 1.817

6.  Association between serum cystatin C level and hemodynamically significant aortic stenosis: a prospective cohort study.

Authors:  Odong Christopher; Xing-Feng Xu; Yi-Fen Lin; Shao-Zhao Zhang; Yi-Quan Huang; Xiang-Bin Zhong; Zhen-Yu Xiong; Tara Scarlett Rosalyn Chen; Chao-Guang Xu; Xiao-Dong Zhuang; Xin-Xue Liao
Journal:  J Geriatr Cardiol       Date:  2021-12-28       Impact factor: 3.327

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.